Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jaime Yeji Kim"'
Autor:
Clémentine Le Magnen, Renu K. Virk, Aditya Dutta, Jaime Yeji Kim, Sukanya Panja, Zoila A. Lopez-Bujanda, Andrea Califano, Charles G. Drake, Antonina Mitrofanova, Cory Abate-Shen
Publikováno v:
Disease Models & Mechanisms, Vol 11, Iss 11 (2018)
Although it is known that inflammation plays a critical role in prostate tumorigenesis, the underlying processes are not well understood. Based on analysis of genetically engineered mouse models combined with correlative analysis of expression profil
Externí odkaz:
https://doaj.org/article/1101e9bdeeee454f88d94a0d8d3d0928
Autor:
Mohammed Alshalalfa, Peter A. Sims, Ilsa Coleman, Jaime Yeji Kim, Angelo M. De Marzo, Onur Ertunc, Junfei Zhao, Renu K. Virk, Felix Y. Feng, Min Zou, Antonina Mitrofanova, Jun Luo, Antonio Rodriguez, Cory Abate-Shen, R. Jeffrey Karnes, Julia Fountain, Hanina Hibshoosh, Juan Arriaga, Sukanya Panja, Peter S. Nelson, Raul Rabadan, Emmanuel S. Antonarakis, Arianna Giacobbe, Busra Ozbek, Chioma J. Madubata, Mark A. Rubin
Publikováno v:
Nat Cancer
Understanding the intricacies of lethal prostate cancer poses specific challenges due to difficulties in accurate modeling of metastasis in vivo. Here we show that NPKEYFP mice (for Nkx3.1CreERT2/+; Ptenflox/flox; KrasLSL-G12D/+; R26R-CAG-LSL-EYFP/+)
Autor:
Andrea Califano, Charles G. Drake, Renu K. Virk, Zoila A. Lopez-Bujanda, Antonina Mitrofanova, Sukanya Panja, Aditya Dutta, Cory Abate-Shen, Clémentine Le Magnen, Jaime Yeji Kim
Publikováno v:
Disease Models & Mechanisms
Disease Models & Mechanisms, Vol 11, Iss 11 (2018)
Disease Models & Mechanisms, Vol 11, Iss 11 (2018)
Although it is known that inflammation plays a critical role in prostate tumorigenesis, the underlying processes are not well understood. Based on analysis of genetically engineered mouse models combined with correlative analysis of expression profil
Autor:
Sukanya Panja, Roseann Zott, David M. Golombos, Aditya Dutta, Elahe A. Mostaghel, Antonina Mitrofanova, Deli Liu, Renu K. Virk, Cory Abate-Shen, Jaime Yeji Kim, Juan Miguel Mosquera, Serge Cremers, Christopher E. Barbieri
Publikováno v:
European urology. 72(4)
Background Although men on active surveillance for prostate cancer (PCa) may benefit from intervention with 5α-reductase inhibitors (5-ARIs), it has not been resolved whether 5-ARIs are effective for delaying disease progression and, if so, whether